Aspiriant Holdings S3’s Schwab US Mid-Cap ETF SCHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$8M Buy
598,986
+7,920
+1% +$108K 3.44% 3
2015
Q3
$7.67M Buy
591,066
+39,375
+7% +$547K 3.53% 3
2015
Q2
$7.84M Buy
551,691
+66,906
+14% +$968K 3.13% 3
2015
Q1
$6.97M Buy
484,785
+38,550
+9% +$538K 2.77% 4
2014
Q4
$6.05M Sell
446,235
-52,500
-11% -$692K 2.5% 5
2014
Q3
$6.43M Buy
498,735
+32,400
+7% +$429K 2.58% 4
2014
Q2
$6.25M Buy
466,335
+79,785
+21% +$1.03M 2.49% 3
2014
Q1
$4.97M Buy
386,550
+320,700
+487% +$4.05M 2.09% 9
2013
Q4
$822K Buy
65,850
+17,250
+35% +$207K 0.32% 75
2013
Q3
$561K Buy
+48,600
New +$548K 0.24% 81

Other funds holding SCHM

Aspiriant Holdings S3's SCHM Position: Q4 2015 in Review

Aspiriant Holdings S3 increased its Schwab US Mid-Cap ETF (SCHM) stake by 1.3% in Q4 2015, buying an estimated $108K and bringing the position to 598,986 shares worth $8M. The position accounts for 3.44% of the portfolio, ranked #3.

Aspiriant Holdings S3 first reported a position in SCHM in Q3 2013 and has held it in 10 quarters since. 195 funds tracked by Wall St. Rank hold SCHM as of Q4 2015.

  • Aspiriant Holdings S3 held 598,986 shares of Schwab US Mid-Cap ETF worth $8M as of Q4 2015.
  • Aspiriant Holdings S3 bought 7,920 Schwab US Mid-Cap ETF shares in Q4 2015, an estimated $108K.
  • Schwab US Mid-Cap ETF made up 3.44% of Aspiriant Holdings S3's portfolio in Q4 2015, its #3 holding.
  • Aspiriant Holdings S3 first reported a position in Schwab US Mid-Cap ETF in Q3 2013 and has held it in 10 quarters since.
  • 195 funds tracked by Wall St. Rank held Schwab US Mid-Cap ETF as of Q4 2015.

Based on Aspiriant Holdings S3's 13F filing for Q4 2015, filed 13 Jan 2016.